Objectives-to determine whether oligoclonal band (OCB) negative multip
le sclerosis is a reliable diagnosis and, if so, whether it has a dist
inctive prognosis. Methods-retrospective and matched prospective compa
rison of the clinical and laboratory features of patients with clinica
l definite multiple sclerosis with and without intrathecal synthesis o
f oligoclonal IgG. Results-thirty four patients were identified with a
pparent OCB negative clinically definite multiple sclerosis. The resul
ts of oligoclonal banding proved to have been equivocal in 14 of 34; t
he clinical diagnosis of multiple sclerosis was questionable in 8 of 3
4. The remaining 12 patients with ''true'' OCB negative multiple scler
osis were significantly less disabled than matched OCB positive contro
ls. Re-examination of CSF-serum pairs from six OCB negative patients s
howed that three remained OCB negative while three showed evidence of
intrathecal synthesis of OCBs. Conclusions-OCB negative clinically def
inite multiple sclerosis is rare and should be diagnosed with caution;
in unequivocal cases it seems to have a relatively benign prognosis.